100 related articles for article (PubMed ID: 10921218)
1. The role of Wobe-Mugos in reducing acute sequele of radiation in head and neck cancers--a clinical phase-III randomized trial.
Kaul R; Mishra BK; Sutradar P; Choudhary V; Gujral MS
Indian J Cancer; 1999; 36(2-4):141-8. PubMed ID: 10921218
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Wobe-Mugos E for reduction of oral mucositis after radiotherapy : results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.
Dörr W; Herrmann T;
Strahlenther Onkol; 2007 Mar; 183(3):121-7. PubMed ID: 17340069
[TBL] [Abstract][Full Text] [Related]
3. [Application of systemic enzyme therapy in combined treatment of patients with pulmonary cancer and malignant thymoma].
Hanul VL; Smolanka II; Ponomar'ova OV
Klin Khir; 2000 Jun; (6):17-9. PubMed ID: 11288269
[TBL] [Abstract][Full Text] [Related]
4. [Wobe-Mugos: a proteolytic enzyme combination for tumor therapy. Documentation No. 7].
Schweiz Rundsch Med Prax; 1987 Dec; 76(51):1430-2. PubMed ID: 3326110
[No Abstract] [Full Text] [Related]
5. Local transrectal enzymatic treatment for chronic nonbacterial prostatitis and prostatodynia: initial clinical experience.
Kerbl K; Zisch R
Tech Urol; 2000 Mar; 6(1):22-5. PubMed ID: 10708143
[TBL] [Abstract][Full Text] [Related]
6. Double-blind pilot-study on the efficacy of enzyme therapy in advanced colorectal cancer.
Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
Przegl Lek; 2000; 57 Suppl 5():142. PubMed ID: 11202281
[TBL] [Abstract][Full Text] [Related]
7. [Systemic enzyme therapy with the preparation Wobe-Mugos E in the combined treatment of lung cancer patients].
Smolanka II
Lik Sprava; 2000; (5):121-3. PubMed ID: 11031472
[TBL] [Abstract][Full Text] [Related]
8. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13.
Elliott EA; Wright JR; Swann RS; Nguyen-Tân F; Takita C; Bucci MK; Garden AS; Kim H; Hug EB; Ryu J; Greenberg M; Saxton JP; Ang K; Berk L;
J Clin Oncol; 2006 May; 24(13):2092-7. PubMed ID: 16648511
[TBL] [Abstract][Full Text] [Related]
9. [The use of enzymes in treating patients with malignant lymphoma with a large tumor mass].
Gubareva AA
Lik Sprava; 1998 Aug; (6):141-3. PubMed ID: 9844901
[TBL] [Abstract][Full Text] [Related]
10. [Effect of the preparation Wobe-Mugos E on parameters of the antioxidant defence system and morphofunctional erythrocyte status in patients with chronic obstructive bronchitis].
Kolomoiets' MIu; Kovalenko SV; Todoriko LD
Lik Sprava; 2000 Sep; (6):100-4. PubMed ID: 11478274
[TBL] [Abstract][Full Text] [Related]
11. Enzyme therapy in patients with advanced colorectal cancer.
Popiela T; Kulig J; Kłek S; Wachol D; Bock PR; Hanisch J
Przegl Lek; 2000; 57 Suppl 5():138-9. PubMed ID: 11202278
[No Abstract] [Full Text] [Related]
12. Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.
Bardet E; Martin L; Calais G; Tuchais C; Bourhis J; Rhein B; Feham N; Alphonsi M
Semin Oncol; 2002 Dec; 29(6 Suppl 19):57-60. PubMed ID: 12577246
[TBL] [Abstract][Full Text] [Related]
13. Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).
Rischin D; Peters L; Fisher R; Macann A; Denham J; Poulsen M; Jackson M; Kenny L; Penniment M; Corry J; Lamb D; McClure B
J Clin Oncol; 2005 Jan; 23(1):79-87. PubMed ID: 15625362
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant accelerated chemotherapy followed by hyperfractionated radiation therapy in patients with operable, locally advanced head and neck carcinoma.
Franchin G; Vaccher E; Gobitti C; Minatel E; Politi D; Talamini R; Di Gennaro G; Savignano G; Trovò MG; Tirelli U; Barzan L
Oral Oncol; 2005 May; 41(5):526-33. PubMed ID: 15878759
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
16. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck.
Garden AS; Harris J; Vokes EE; Forastiere AA; Ridge JA; Jones C; Horwitz EM; Glisson BS; Nabell L; Cooper JS; Demas W; Gore E
J Clin Oncol; 2004 Jul; 22(14):2856-64. PubMed ID: 15254053
[TBL] [Abstract][Full Text] [Related]
17. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the preparation Wobe-Mugos E on the functional and biochemical status of the kidneys in the polyuric stage of sublimate-induced nephropathy].
Rohovyĭ IuIe; Myslyts'kyĭ VF; Filipova LO; Shapovalov VP; Mahalias MV; Maĭkan RI; Chortyk IuB
Fiziol Zh (1994); 2000; 46(3):51-6. PubMed ID: 11059387
[TBL] [Abstract][Full Text] [Related]
19. Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck--a phase III trial from a single institution in India.
Ghoshal S; Goda JS; Mallick I; Kehwar TS; Sharma SC
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):212-20. PubMed ID: 18343310
[TBL] [Abstract][Full Text] [Related]
20. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]